Q&A: How Chemoimmunotherapy Has Impacted Survival in Veterans With ES-SCLC, Brain Metastases
Veterans with extensive-stage small cell lung cancer (ES-SCLC), including those with brain metastases, have seen improvements in survival since chemoimmunotherapy became standard of care, according to findings presented at the 2026 ASCO Annual Meeting. …